Viewing Study NCT06050694


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-26 @ 12:59 AM
Study NCT ID: NCT06050694
Status: RECRUITING
Last Update Posted: 2025-04-06
First Post: 2023-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Feasibility Trial of Glofitamab in a Response Adapted Approach Incorporating Interim FDG PET and ctDNA to Optimize Primary Therapy of DLBCL (GRAIL)
Sponsor: University Health Network, Toronto
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module